Hypoglycemia

Immunology·MeSH: Hypoglycemia

11 drugs in development·9 companies·2 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
baqsimi	Amphastar Pharmaceuticals, Inc. (AMPH)
Gvoke	Xeris Biopharma Holdings, Inc. (XERS)

Phase 3(2)

Drug	Company
avexitide	Amylyx Pharmaceuticals, Inc. (AMLX)
avexitide	Eiger BioPharmaceuticals, Inc. (EIGR)

Phase 2(6)

Drug	Company
anakinra	ENANTA PHARMACEUTICALS INC (ENTA)
anakinra	Cidara Therapeutics, Inc. (CDTX)
empagliflozin	Cidara Therapeutics, Inc. (CDTX)
imapextide	MBX Biosciences, Inc. (MBX)
mbx 1416	MBX Biosciences, Inc. (MBX)
mbx-2982	CymaBay Therapeutics, Inc. (CBAY)

Preclinical(1)

Drug	Company
spr204	SPRUCE BIOSCIENCES, INC. (SPRB)

BioSniper tracks 11 drugs in development for Hypoglycemia across 9 companies.

There are 2 clinical trials targeting Hypoglycemia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.